# Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome

> **NCT06723002** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Monastir** · enrollment: 300 (estimated)

## Conditions studied

- Acute Coronary Syndrome (ACS)
- Reactive Hyperemia
- Endothelial Dysfunction

## Interventions

- **DRUG:** Atherolive 500mg/day
- **DRUG:** Atherolive 1000/day
- **DRUG:** Placbo_Atherolive

## Key facts

- **NCT ID:** NCT06723002
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06723002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06723002, "Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06723002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*